Open AccessShould the Use of Biologic Agents in Patients With Renal and Lung Cancer Affect Our Surgical Management of Femoral Metastases?
Author(s) -
Christina J. Gutowski,
Benjamin Zmistowski,
Nicola Fabbri,
Patrick J. Boland,
John H. Healey
Publication year - 2018
Publication title -
clinical orthopaedics and related research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.178
H-Index - 204
eISSN - 1528-1132
pISSN - 0009-921X
DOI - 10.1097/corr.0000000000000434
Subject(s) - medicine , renal cell carcinoma , surgery , lung cancer , chemotherapy , lung , internal fixation , oncology
Biologic agents may prolong survival of patients with certain kidney and lung adenocarcinomas that have metastasized to bone, and patient response to these agents should be considered when choosing between an endoprosthesis and internal fixation for surgical treatment of femoral metastases.